Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      AstraZeneca Lokelma gets Chinese approval for treating hyperkalaemia

      AstraZeneca Lokelma gets Chinese approval for treating hyperkalaemia

      Medical Dialogues Bureau7 Jan 2020 9:30 AM IST
      New Delhi: AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) has been approved in China for the treatment of adult patients with hyperkalaemia...
      Merck Keytruda, chemotherapy combination shows mixed results in phase 3 trial for lung cancer

      Merck Keytruda, chemotherapy combination shows mixed results in phase 3 trial for lung cancer

      Medical Dialogues Bureau7 Jan 2020 9:15 AM IST
      While the blockbuster drug showed improvement in overall survival for patients treated with Keytruda in combination with chemotherapy, it did not meet...
      Pulmatrix enters kinase inhibitor licensing pact with Lung Cancer Initiative at JnJ

      Pulmatrix enters kinase inhibitor licensing pact with Lung Cancer Initiative at JnJ

      Medical Dialogues Bureau6 Jan 2020 9:20 AM IST
      Through the agreement, the Lung Cancer Initiative gains an option to access a portfolio of narrow spectrum kinase inhibitors intended for development...
      Biostage provides update on USFDA investigational NDA for Cellspan Esophageal Implant

      Biostage provides update on USFDA investigational NDA for Cellspan Esophageal Implant

      Medical Dialogues Bureau6 Jan 2020 9:15 AM IST
      Biostage received a preliminary communication from the FDA on November 27th, allowing the Company to begin preparing its responses.New Delhi:...
      WuXi STA Pharma opens oligonucleotide API manufacturing facility in China

      WuXi STA Pharma opens oligonucleotide API manufacturing facility in China

      Medical Dialogues Bureau5 Jan 2020 9:45 AM IST
      New Delhi: STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – recently announced the opening of its large-scale oligonucleotide...
      Amgen, BeiGene collaborate to expand oncology presence in China

      Amgen, BeiGene collaborate to expand oncology presence in China

      Medical Dialogues Bureau5 Jan 2020 9:30 AM IST
      New Delhi: Amgen, recently announced the successful closing of the transaction to enter into a strategic collaboration with BeiGene that will...
      OPOS, Fullpower enter partnership to create-The First 24/7 Opioid Compliance Solution

      OPOS, Fullpower enter partnership to create-The First 24/7 Opioid Compliance Solution

      Medical Dialogues Bureau5 Jan 2020 9:00 AM IST
      New Delhi: Fullpower Technologies, the sleep technology company and OPOS, the opioid optimization company” announced a partnership to create “The...
      Patent Infringement: Case against Natco Pharma in US court over generic version of cancer drug Lonsurf

      Patent Infringement: Case against Natco Pharma in US court over generic version of cancer drug Lonsurf

      Medical Dialogues Bureau4 Jan 2020 2:03 PM IST
      In a petition filed in the United States District Court for the District Court of Delaware on December 30, Taiho alleged that the Natco Pharma's...
      Dr Reddys secures shareholders nod for amalgamation of Dr Reddys Holdings into company

      Dr Reddys secures shareholders nod for amalgamation of Dr Reddys Holdings into company

      Medical Dialogues Bureau4 Jan 2020 12:50 PM IST
      The board of Dr Reddy's Laboratories had on July 29, 2019, approved the amalgamation of Dr Reddy's Holdings Ltd, an entity held by the promoter group...
      Novo Nordisk to offer free insulin to US patients

      Novo Nordisk to offer free insulin to US patients

      Medical Dialogues Bureau4 Jan 2020 9:30 AM IST
      Novo Nordisk said in September U.S. patients can buy three vials or two packs of pens of its analogue insulins for $99, following similar moves by...
      Merck, Novartis, Allergan to raise US drug prices for 100 drugs

      Merck, Novartis, Allergan to raise US drug prices for 100 drugs

      Medical Dialogues Bureau4 Jan 2020 9:20 AM IST
      New Delhi: Novartis AG, Merck & Co Inc and Allergan Plc were among companies that raised U.S. prices on more than 100 prescription medicines on...
      Novo Nordisk names Vikrant Shrotriya as Managing Director for India business

      Novo Nordisk names Vikrant Shrotriya as Managing Director for India business

      Medical Dialogues Bureau3 Jan 2020 2:21 PM IST
      Vikrant Shrotriya was recently working in the GCC (Gulf Cooperation Council) countries wherein he was Vice-President for company's GCC business and...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok